登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600340 证券简称：华夏幸福 公告编号：2026-011 华夏幸福基业股份有限公司关于 补选仇文丽女士为第八届董事会 非独立董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性及完整性承担法律责任。 华夏幸福基业股份有限公司（以下简称"公司"）股东中国平安人寿保险股份有限公司提名仇文丽女士 （个人简历见附件）为公司第八届董事会非独立董事候选人，任期自股东会审议通过之日起至第八届董 事会届满之日止。 候选人的任职资格已经过第八届董事会提名委员会2026年第一次会议审议通过，公司于2026年1月20日 召开第八届董事会第三十八次会议，会议审议通过了《关于补选仇文丽女士为第八届董事会非独立董事 的议案》，并同意将上述议案提交公司2026年第一次临时股东会审议。 股东会审议通过本次补选非独立董事后，公司第八届董事会成员共九名，董事会中兼任公司高级管理人 员以及由职工代表担任的董事人数总计未超过公司董事总数的二分之一。 特此公告。 华夏幸福基业股份有限公司董事会 2026年1月21日 仇文 ...

Core Viewpoint - The company held its fourth temporary board meeting of the eleventh session, where several key resolutions were passed, including the reappointment of an accounting firm and the election of a new committee member [1][2][7][22]. Group 1: Board Meeting Resolutions - The board approved the election of Mr. Luo Liang as a member of the Audit Committee and the Remuneration and Appraisal Committee, effective immediately [2]. - The composition of the Audit Committee after the election includes Luo Chunhua, Jin Xiaogang, Zheng Chunyan, You Kuangling, and Luo Liang, with Luo Chunhua as the convener [3]. - The Strategic Committee consists of You Kuangling, Jin Xiaogang, Luo Chunhua, Zheng Chunyan, and Tang Ying, with You Kuangling as the convener [4]. - The Remuneration and Appraisal Committee includes Jin Xiaogang, Luo Chunhua, Zheng Chunyan, Wang Yingyi, and Luo Liang, with Jin Xiaogang as the convener [5]. - All resolutions were passed with unanimous support, receiving 7 votes in favor, 0 against, and 0 abstentions [6][8][11]. Group 2: Reappointment of Accounting Firm - The board approved the reappointment of Zhonghui Certified Public Accountants (Special General Partnership) as the company's accounting firm for the year 2025 [7][22]. - Zhonghui Certified Public Accountants has been in operation since December 2013 and has a strong background in securities services, with 694 registered accountants and 289 who have signed audit reports for securities services [15][16]. - The total audit fee for 2025 is set at 1.8 million yuan, which includes 1.35 million yuan for financial audits and 450,000 yuan for internal control audits [20]. - The reappointment is subject to approval at the upcoming shareholders' meeting [23]. Group 3: Upcoming Shareholders' Meeting - The first temporary shareholders' meeting for 2026 is scheduled for January 5, 2026, at 14:00, combining on-site and online voting methods [26]. - The meeting will take place at a specified location in Beijing, and shareholders can vote through the Shanghai Stock Exchange's online voting system [26][27]. - The meeting will address the resolutions passed in the board meeting, which have been disclosed on the Shanghai Stock Exchange's website [29].

Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]

Meeting Overview - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025 [1][2] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [1][10] Meeting Details - The meeting will take place at 2:45 PM on September 8, 2025, with network voting available throughout the day [2][3] - Shareholders can vote either in person or via online platforms provided by the Shenzhen Stock Exchange [4][16] Attendance and Registration - Shareholders registered by the close of business on September 3, 2025, are eligible to attend [5][6] - Registration for attendance can be done in person or through authorized representatives [12][13] Agenda Items - The meeting will include proposals for amending the company's articles of association and electing a non-independent director [15][10] - A special resolution requires approval from at least two-thirds of the voting rights present [10][11] Voting Procedures - Voting will be conducted through both physical attendance and online systems, with specific time slots for online voting [3][18] - All proposals are non-cumulative voting items, and the first valid vote will be considered in case of duplicate votes [17][19] Additional Information - The company will not cover travel expenses for attending shareholders [20] - Contact information for inquiries is provided, including phone and fax numbers [21]

Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to ensure the protection of shareholders' legal rights and maintain the order and efficiency of the meeting [1][2]. Meeting Details - The meeting is scheduled for July 31, 2025, at 13:30, located at the company's conference room in Shanghai [5]. - Voting will be conducted through a combination of on-site and online methods, with specific time slots for internet voting [5]. Meeting Agenda - The agenda includes sign-in, distribution of materials, and registration for speaking [6]. - The chairman will announce the number of attending shareholders and their voting rights before proceeding with the meeting [6]. Proposals for Consideration - Proposal 1: Election of a new non-independent director to replace the resigned director, with the candidate being Mao Xinyong [6][7]. - Proposal 2: Adjustment of the 2025 director remuneration plan, specifically for non-independent directors not holding executive positions, proposing a consultant allowance of RMB 100,000 per year [8]. - Proposal 3: Formulation and revision of certain internal governance systems, in compliance with relevant laws and regulations [9][10]. Additional Proposals - Several additional proposals regarding the management of various internal systems, including external guarantees, external investments, and fundraising management, are also set for discussion [10][11].